Association of Sphingolipids with All-Cause and Cardiovascular Death in Patients with Kidney Failure Treated with Maintenance Hemodialysis
Journal of the American Society of Nephrology · 2026-06 · 37 (6) · 1237-1247
DOI: 10.1681/asn.0000000982 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of the American Society of Nephrology, online erschienen am 19.12.2025. Verfasst von Benjamin Lidgard und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Washington, Seattle, Washington. Hauptthemen laut MEDLINE: Renal Dialysis, Cardiovascular Diseases, Sphingolipids, Kidney Failure, Chronic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, NIDDK NIH HHS, National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
Key Points Sphingolipids with long fatty acids (16–18 carbons) were associated with all-cause and cardiovascular death in patients treated with hemodialysis. Sphingolipids with very-long fatty acids (20+ carbons) were associated with lower risk of all-cause and cardiovascular death in dialysis patients.
Background
Patients with kidney failure on hemodialysis are at a higher risk for death, especially cardiovascular death. Statins (which improve outcomes in general populations) do not improve outcomes in dialysis patients. Sphingolipids are mechanistically associated with cardiovascular disease and may represent novel, modifiable risk factors for death in patients with kidney failure. We aimed to examine the associations of sphingolipids with death specifically in dialysis patients.
Methods
Using data from the Hemodialysis (HEMO) Study (a multicenter factorial trial of dose and flux), we measured 16 sphingolipids (ceramides-16:0, 18:0, 20:0, 22:0, 24:0, and 24:1; hexosylceramides-16:0, 22:0, and 24:0; lactosylceramide-16:0; and sphingomyelins 14:0, 16:0, 18:0, 20:0, 22:0, and 24:0) at baseline only in 927 participants with available stored serum using targeted liquid chromatography–tandem mass spectrometry. The primary outcome was all-cause death, with physician-adjudicated cause (cardiovascular versus noncardiovascular) as a secondary outcome. We examined the associations of sphingolipids with death using Cox regressions, controlling the false discovery rate
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of Washington, Seattle, Washington.
- New York Academy of Medicine, New York, New York.
- Department of Medicine, Georgetown University, Washington, DC.
ORCID-Profile: Benjamin Lidgard, Andrew N Hoofnagle, Leila R Zelnick, Ian H de Boer, Amanda M Fretts, Jason G Umans, Nisha Bansal, Rozenn N Lemaitre
Förderung
- NCATS NIH HHS
- NIDDK NIH HHS
- National Center for Advancing Translational Sciences
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Lidgard, B., Hoofnagle, A. N., Zelnick, L. R., de Boer, I. H., Jensen, P., Fretts, A. M., Siscovick, D. S., Umans, J. G., Bansal, N., & Lemaitre, R. N. (2026). Association of Sphingolipids with All-Cause and Cardiovascular Death in Patients with Kidney Failure Treated with Maintenance Hemodialysis. Journal of the American Society of Nephrology, 37(6), 1237-1247. https://doi.org/10.1681/asn.0000000982
Vancouver
Lidgard B, Hoofnagle AN, Zelnick LR, de Boer IH, Jensen P, Fretts AM, et al. Association of Sphingolipids with All-Cause and Cardiovascular Death in Patients with Kidney Failure Treated with Maintenance Hemodialysis. Journal of the American Society of Nephrology. 2026;37(6):1237-1247. doi:10.1681/asn.0000000982
BibTeX
@article{Lidgard2026,
author = {Lidgard, Benjamin and Hoofnagle, Andrew N and Zelnick, Leila R and de Boer, Ian H and Jensen, Paul and Fretts, Amanda M and Siscovick, David S and Umans, Jason G and Bansal, Nisha and Lemaitre, Rozenn N},
title = {Association of Sphingolipids with All-Cause and Cardiovascular Death in Patients with Kidney Failure Treated with Maintenance Hemodialysis},
journal = {Journal of the American Society of Nephrology},
year = {2026},
volume = {37},
number = {6},
pages = {1237--1247},
doi = {10.1681/asn.0000000982}
}
EUVIMED